Search results
Showing results for
The world’s number-one treatment for malaria is on the brink of failure because of a new strain of drug-resistant parasites — unless health policymakers take action. Professor Sir Nicholas White says that the mosquito-borne parasite responsible for severe malaria is now showing resistance to the prime treatment, Artemisinin Combination Therapy (ACT), across South-East Asia. If this resistance jumps to Africa, he warns, the tragedy will be on a massive scale.
Innovative housing design cools homes, saves lives in Africa
22 April 2026
Simple improvements in housing can have a profound impact on public health in sub-Saharan Africa, say researchers who designed Star Home, a novel double-story house that provides an insect-proof, cleaner, cooler and smoke-free environment with reliable water and sanitation in Tanzania.
OUCRU joins WHO Coronavirus Network
17 April 2026
OUCRU, hosted by the Hospital for Tropical Diseases (HTD) in Ho Chi Minh City, Vietnam, has joined the World Health Organisation (WHO) Coronavirus Network (CoViNet), a global network to detect and monitor coronaviruses of public health importance.
From MODRA to Wellcome Sanger Fellowship: Dr Le Thanh Hoang Nhat reflects on Growth and Connection
13 April 2026
Dr Nhat, a MODRA alumnus, has been awarded a Wellcome Sanger Fellowship. Reflecting on his journey, he highlights how mentorship, regional collaboration and focused training through MODRA helped shape a competitive research proposal and strengthen his direction as an independent researcher.
Reimagining community mental health in Kenya through the 'Nyumba Kumi' model
13 April 2026
A new community-based mental health approach in Kenya draws on the Nyumba Kumi model, where trusted local elders support small household groups. Combining cultural practice with psychological research, the project aims to address limited access to care by enabling early intervention and prevention, empowering communities to take a leading role in improving mental well-being.
Integration of Infection Prevention and Control into the Antimicrobial Stewardship Programme – 60HN ASPARNet
10 April 2026
The study titled “Evaluating Antimicrobial Stewardship strategies and capacity building through Participatory Action Research and a Network approach in Vietnam” (60HN – ASPARNet) continues to implement key activities to promote AMS programmes across hospitals participating in the network.
GRAM to host 27th and 29th April webinar on AMR insights for policy
8 April 2026
The Global Research on Antimicrobial Resistance (GRAM) Project is inviting global AMR stakeholders to attend its 27th and 29th April webinar, ‘Information to action: Antimicrobial resistance insights for policy’. Led by GRAM partners at IHME, the session will explore successful interventions to combat AMR, and conclude with a demonstration of data tools that may assist policymakers and researchers in quantifying the impact of interventions targeting AMR.
Study brings together prognostic models for visceral leishmaniasis outcomes
7 April 2026
A BMJ Public Health review by IDDO researchers analysed 12 prognostic models for visceral leishmaniasis, identifying significant gaps and high risk of bias. Developed mainly in Brazil and East Africa, these models lack applicability in high-burden regions like the Indian subcontinent. The findings support improved model development and better-informed clinical decision-making.
IHTM students take policy briefs to UK Parliament
31 March 2026
11th cohort of students present to Parliament on global health's most pressing challenges
New £5 million Wellcome Discovery Award to transform treatment for tuberculous meningitis
24 March 2026
Tuberculous meningitis remains highly lethal despite standard treatment, and recent trials show current antibiotic and corticosteroid approaches are not good enough. A new international research programme, funded by Wellcome, aims to develop improved therapies by studying disease mechanisms, testing novel drugs and identifying biomarkers, aiming to guide safer, more effective treatment and reduce global deaths.
Championing Ethical Research: Dorcas Kamuya on Community, Science, and Women in Leadership
23 March 2026
Dorcas Kamuya’s journey highlights the impact of ethical, community-centred research. From rural Kenya to scientific leadership, she champions equity, mentorship, and inclusive research practices. Her work ensures that science respects community voices while advancing health systems, inspiring the next generation of women in research.
Advancing Epilepsy Care in Africa: Insights from the EPInA Dissemination Meeting in Nairobi
23 March 2026
The EPInA project (Epilepsy Pathway Innovations in Africa) convened stakeholders in Nairobi to advance epilepsy care across Africa, supporting WHO’s Intersectoral Global Action Plan framework. Through community engagement and digital innovation, the initiative improves diagnosis, treatment and stigma reduction. The meeting emphasised translating evidence into action, strengthening health systems, and expanding access to equitable neurological care.
Strengthening intensive care capacity in Vietnam through international training
20 March 2026
OUCRU held its annual intensive care training for healthcare workers on 12–13 March 2026 in Ho Chi Minh City. The two-day programme brought together specialists from the UK and Vietnam to share the latest knowledge and skills in critical care medicine.
Oxford and Serum Institute of India sign IP license agreement to advance NipahB vaccine candidate
17 March 2026
The University of Oxford and Serum Institute of India Pvt. Ltd. (SII), a Cyrus Poonawalla Group company and the world’s largest vaccine manufacturer, have signed an Intellectual Property license agreement to advance the development and manufacture of the ChAdOx1 NipahB vaccine candidate. Professor Brian Angus is Chief Investigator of the trial.
From Factory Worker to Infectious Diseases Scientist: The Story of OUCRU Indonesia’s Suwarti
10 March 2026
OUCRU Indonesia highlights the remarkable journey of Dr Suwarti, a scientist who rose from factory work to infectious diseases research. Through determination, education, and mentorship, Suwarti built a scientific career addressing critical public health challenges. Her story reflects OUCRU’s commitment to developing local research talent and expanding scientific opportunity in Indonesia.
Behind the Title: Becoming an Oxford Professor (at NDM), featuring Professor Phaik Yeong Cheah
7 March 2026
The Behind the Title: Becoming an Oxford Professor (at NDM) series highlights the diverse journeys of our professors and the many paths that lead to academic leadership. By sharing their journeys we aim to showcase the breadth of backgrounds, disciplines, and experiences represented across the Department, demonstrating that there is no single route to becoming a professor at Oxford. In our first feature, we hear from Professor Phaik Yeong Cheah, Head of Bioethics and Engagement at the Mahidol Oxford Tropical Medicine Research Unit (MORU), Nuffield Department of Medicine, based in Bangkok.
Oxford joins new West Africa consortium to accelerate climate and health solutions
5 March 2026
Researchers from the University of Oxford have joined African universities and regional experts who are working with Wellcome to establish new science and policy consortiums that will address the escalating public health crisis driven by climate change - saving lives and livelihoods.
Why the Way We Use Antibiotics Matters More Than We Think
3 March 2026
Antimicrobial resistance is a growing global threat driven by everyday antibiotic use, especially in informal healthcare settings. In rural Vietnam, women caregivers often rely on antibiotics to manage common symptoms amid limited healthcare access. Collab Lab highlights how social context, uncertainty and caregiving pressures shape antibiotic decisions and contribute to rising resistance.
Strengthening Pharmacy resilience in public health crises in Nigeria
23 February 2026
Dr Rachel Obonose Titus developed evidence-based Standard Operating Procedures (SOPs) to strengthen Nigerian community pharmacies during public health emergencies. Inspired by COVID-19 challenges, her work translates frontline experiences into practical policy tools. Through an AfOx Visiting Fellowship, she advanced evaluation and stakeholder engagement, aiming for national adoption and improved health system resilience.
My mission is to strengthen women’s futures in Congo and Africa through education and partnerships
20 February 2026
Sarah Mugoli Balekage’s journey from the Democratic Republic of Congo to Oxford University is driven by faith and a commitment to empowering women through education. An Africa Oxford Initiative Scholar, she is pursuing African studies to advance social entrepreneurship and community advocacy, aiming to promote unity, development and opportunity across Africa.
New Study highlights demographic shift of visceral leishmaniasis to older patients and increased incidence of relapses in Brazil
18 February 2026
A new study into visceral leishmaniasis (VL) in Brazil has created the most comprehensive picture of the disease in the country, and highlighted trends including more older patients being diagnosed with the disease and more patients presenting with relapses over time.